Contraindications: This peptide has 3 known contraindication(s). See Safety section
Anti-AgingUse Caution

AEDG

Also known as: Epitalon component, Pineal tetrapeptide, Ala-Glu-Asp-Gly

Research Only
Preclinical
MW: 418.37 g/mol • 15 amino acids

AEDG is a tetrapeptide component of Epitalon derived from the pineal gland that may support telomere maintenance and cellular longevity. Research suggests it may influence gene expression, neurogenesis, and circadian rhythm regulation. Studies indicate potential anti-aging properties through telomere length preservation.

â–¶ AEDG in 30 Seconds

Research overview only. Not medical advice.

Half-Life

Not yet established in human studies

Typical Dose

Not yet established in human studies

Frequency

Not yet established in human studies

Routes

Subcutaneous

Overview

AEDG is a tetrapeptide (Ala-Glu-Asp-Gly) identified as a bioactive component of the pineal gland-derived polypeptide complex. Research suggests this peptide may play a role in cellular longevity, neurogenesis, and circadian rhythm regulation. Studies indicate AEDG may influence telomere length and gene expression patterns associated with aging processes.

The peptide has been investigated primarily in laboratory settings for its potential anti-aging properties and effects on cellular differentiation. While research is limited to preclinical studies, early findings suggest AEDG may support cellular health through epigenetic mechanisms and telomere maintenance.

Important: AEDG is not approved for human use and remains an experimental research compound.

Mechanism of Action

AEDG appears to exert its effects through several potential mechanisms:

Telomere Maintenance: Research indicates AEDG may influence telomere length in human blood lymphocytes, potentially supporting cellular longevity and reducing markers of cellular aging.

Gene Expression Regulation: Studies suggest the peptide may modulate gene expression patterns, particularly those involved in neurogenesis and circadian rhythm regulation. This may occur through epigenetic mechanisms affecting protein synthesis.

Neurogenic Support: Laboratory studies indicate AEDG may stimulate gene expression and protein synthesis during neurogenesis, potentially supporting neural development and maintenance.

Circadian Rhythm Modulation: Research suggests the peptide may regulate expression of circadian rhythm genes, particularly during accelerated aging of pineal gland tissue.

Research Summary

Current research on AEDG consists of 10 preclinical studies with no registered clinical trials. The peptide has been investigated primarily in cell culture and tissue studies.

Key Studies

Neurogenesis and Gene Expression (2020) A study published in Molecules examined AEDG's effects on neurogenesis, finding that the peptide stimulated gene expression and protein synthesis. Researchers suggested possible epigenetic mechanisms underlying these effects.

Telomere Length Study (2019) Research published in the Bulletin of Experimental Biology and Medicine investigated AEDG's effects on telomere length and mitotic index in PHA-stimulated human blood lymphocytes. The study found measurable effects on both parameters.

Circadian Rhythm Regulation (2020) A study in Advances in Gerontology examined AEDG's effects on circadian rhythm gene expression during pineal gland accelerated aging, suggesting potential regulatory effects on biological clock mechanisms.

Pineal Gland Identification (2017) Research published in the Bulletin of Experimental Biology and Medicine confirmed the identification of AEDG peptide within the polypeptide complex of the pineal gland, establishing its natural occurrence.

Stem Cell Protection (2020) A study in Stem Cell Reviews and Reports investigated short peptides, including AEDG, for their protective effects on oral stem cells during aging processes.

Dosage Guidelines

Dosage information for AEDG is not yet established in human studies. The peptide remains in experimental stages with no standardized protocols available.

ParameterValue
Typical doseNot yet established
FrequencyNot yet established
Cycle lengthNot yet established
AdministrationResearch suggests subcutaneous injection

Research Note: All dosage information must be extrapolated from preclinical studies and requires further investigation in human subjects.

Safety Profile

The safety profile of AEDG in humans is not yet established due to the lack of clinical trials. Potential considerations based on its mechanisms include:

Theoretical Concerns:

  • Unknown effects on cellular proliferation
  • Potential interactions with circadian rhythm medications
  • Unclear long-term effects of telomere manipulation

Monitoring Recommendations:

  • Complete blood count if used experimentally
  • Liver and kidney function assessment
  • Sleep pattern monitoring due to circadian effects

Contraindications:

  • Active malignancy (theoretical risk of promoting tumor growth)
  • Pregnancy and breastfeeding (unknown fetal effects)
  • Age under 18 (no pediatric data)

Stacking

Due to limited research, stacking protocols for AEDG are theoretical and based on its relationship to other peptides:

With Epitalon:

  • May provide synergistic anti-aging effects
  • Consider alternating cycles rather than concurrent use
  • Monitor for cumulative effects on sleep patterns

General Considerations:

  • Start with single peptide protocols
  • Monitor individual response before combining
  • Consider timing related to circadian rhythm effects

Important Note: All stacking recommendations are theoretical due to the experimental nature of AEDG and lack of human safety data.

References

  1. AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism. (2020). Molecules (Basel, Switzerland). DOI PubMed
  2. [AEDG peptide regulates human circadian rhythms genes expression during pineal gland accelerated aging.]. (2020). Advances in gerontology = Uspekhi gerontologii. PubMed
  3. Identification of Peptide AEDG in the Polypeptide Complex of the Pineal Gland. (2017). Bulletin of experimental biology and medicine. DOI PubMed
  4. Effect of Peptide AEDG on Telomere Length and Mitotic Index of PHA-Stimulated Human Blood Lymphocytes. (2019). Bulletin of experimental biology and medicine. DOI PubMed
  5. Peptide Regulation of Cell Differentiation. (2020). Stem cell reviews and reports. DOI PubMed
  6. Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties. (2025). International journal of molecular sciences. DOI PubMed
  7. Short Peptides Protect Oral Stem Cells from Ageing. (2020). Stem cell reviews and reports. DOI PubMed
  8. Peptide Regulation of Skin Fibroblast Functions during Their Aging In Vitro. (2016). Bulletin of experimental biology and medicine. DOI PubMed
  9. Effect of short peptides on neuronal differentiation of stem cells. (2019). International journal of immunopathology and pharmacology. DOI PubMed
  10. Peptides Restore Functional State of the Kidneys During Cisplatin-Induced Acute Renal Failure. (2015). Bulletin of experimental biology and medicine. DOI PubMed

Get Our Free Peptide Research Guide

100 essential tips for safe peptide research, delivered as a free PDF.

Need Research Supplies?

Syringes, bacteriostatic water, vials, alcohol swabs, and more. Everything you need for peptide research.

Browse Supplies